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2:30 – 4:30 PM, MONDAY AFTERNOON 
FUNDAMENTALS: SUPRAMOLECULAR CHEMISTRY 
AND NON-COVALENT COMPLEXES 
Evan Williams, presiding 
Room: Ballroom HJ 
MOA pm 2:30 Native Mass Spectrometry Provides a First 
Structural Model for the 405 kDa CRISPR-
RNA Antiviral Defense System; Esther Van 
Duijn1; Arjan Barendregt1; Jelle Bultema3;
Matthijs M. Jore2; Magnus Lundgren2; Stan J. 
Brouns2; Blake Wiedenheft4; Jennifer A. 
Doudna4; Egbert J. Boekema3; John van der 
Oost2; Albert J.R. Heck1; 1Utrecht University, 
Utrecht, Netherlands; 2Wageningen University, 
Wageningen, Netherlands; 3University of 
Groningen, Groningen, Netherlands; 4UC
Berkeley, Berkeley, CA
MOA pm 2:50 Ion Mobility Spectrometry/Mass Spectrometry 
Reveals Conformational Conversion from 
Random Assembly to ȕ-Sheet-Rich Oligomers 
in Amyloid Fibril Forming Peptides; Christian 
Bleiholder1; Nicholas Dupuis2; Thomas 
Wyttenbach3; Michael T. Bowers 3; 1University of 
California, SB, Santa Barbara, CA; 2UC Santa 
Barbara, Goleta, CA; 3University of California 
San, Santa Barbara, CA
MOA pm 3:10 Surface-Induced Dissociation Lends Insight on 
Subunit Arrangement in Non-Covalent Protein 
Complexes; Anne E. Blackwell; Eric D. Dodds; 
Christopher M. Jones; Vicki H. Wysocki; 
University of Arizona, Tucson, AZ
MOA pm 3:30 Analysis of Big Macromolecular Soluble and 
Membrane Protein Complexes for ESI-MS;
Nina Morgner; Helena Hernandez; Min Zhou; 
Laura A Lane; Carol Robinson; University of 
Oxford, Oxford, UK
MOA pm 3:50 Supercharged HD Exchange-MS for Top-down 
Structural Characterization of Proteins and 
Complexes; Harry J. Sterling; Evan R. Williams; 
University of California, Berkeley, CA
MOA pm 4:10 Noncovalent Molecular Recognition of 
Protonated Peptidomimetic Bases by 18-
Crown-6: Structure Versus Energetics; Mary T.
Rodgers; Yu Chen; Wayne State University, 
Detroit, MI
2:30 – 4:30 PM, MONDAY AFTERNOON 
ADVANCES IN ION IMAGING 
Michelle Reyzer, presiding 
Room: Ballroom ACE 
MOB pm 2:30 Imaging Mass Spectrometry: Current 
Performance and Upcoming Challenges; Pierre 
Chaurand; University of Montreal, Montreal, 
Canada
MOB pm 2:50 Correlation of MS, MRI, and Optical Images 
for 3D Assessment of the Tumor 
Microenvironment; Erin H. Seeley1; Julie A. 
Sterling1; Amelie R. Gillman1; Tuhin K. Sinha2;
Rachelle W. Johnson1; Thomas E. Yankeelov1;
John C. Gore1; Gregory R. Mundy1; Lynn M. 
Matrisian1; Richard M. Caprioli1; 1Vanderbilt
University, Nashville, TN; 2University of 
California San Fransisco, San Fransisco, CA
MOB pm 3:10 Revealing Bacterial Post-Translationally 
Modified Cannibalistic Metabolic Exchange 
Factors with Imaging Mass Spectrometry;
Pieter Dorrestein; University of California, San 
Diego, Skaggs School, La Jolla, CA
MOB pm 3:30 More Information in Less Time: Strategies for 
High Spatial & High Mass Spectral Resolution 
Imaging Utilizing a Hybrid LIT-Orbitrap MS;
David C. Perdian; Edward S. Yeung; Young Jin 
Lee; Iowa State University, Ames Laboratory US 
DOE, Ames, IA
MOB pm 3:50 Going Beyond Images: Exploration of 
Hormone Processing Pathways in Diabetic 
Mouse Models via Mass Spectral Imaging and 
Data-Mining; Raf Van de Plas1, 4; Dirk Vander 
Mierde2; Katleen Lemaire2; Bart De Moor1, 4;
Peter In't Veld5; Frans Schuit2; Etienne 
Waelkens3, 4; 1K.U.Leuven - SCD-SISTA 
Bioinformatics, Leuven, Belgium; 2K.U.Leuven - 
Gene Expression Unit, Leuven, Belgium; 
3K.U.Leuven - Lab of Protein Phosph. and 
Proteomics, Leuven, Belgium; 4K.U.Leuven - 
ProMeta Core Facility, Leuven, Belgium; 
5Brussels Free University-Diabetes Research 
Center, Brussels, Belgium
MOB pm 4:10 Intraoperative Identification of Malignant 
Gastrointestinal Tumors and Proximal 
Metastases by Rapid Evaporative Ionization 
Mass Spectrometry; Julia Balog2; Tamas 
Szaniszlo2; Daniel Szalay2; Lajos Godorhazy2;
Laszlo Sasi Szabo4; Karl C Schaefer1; Miklos 
Toth3; Zoltan Takats1; 1Justus-Liebig-University, 
Giessen, Germany; 2Medimass Inc., Budapest, 
Hungary; 3Semmelweis University, Budapest, 
Hungary; 4University of Debrecen, Debrecen, 
Hungary
2:30 – 4:30 PM, MONDAY AFTERNOON 
MS OF SYNTHETIC POLYMERS 
Barbara Larsen, presiding 
Room: Ballroom BDF 
MOC pm 2:30 Characterization of Enzymatically-Catalyzed 
Polycaprolactones; William E. Wallace1; Atul 
Bhangale2; Santanu Kundu1; Charles M. 
Guttman1; Kathleen M. Flynn1; Richard A. 
Gross2; Kathryn L. Beers1; 1National Institute of 
Standards & Technology, Gaithersburg, MD; 
2Polytechnic Institute of New York University, 
New York, NY
MOC pm 2:50 Library of Polymer Architectures Examined 
by Ion Mobility Spectrometry-Mass 
Spectrometry; Sarah Trimpin1; Hoskins Jesika2;
Kanchana Wijerathne1; Ellen D. Inutan 1; Scott M. 
Grayson2; 1Wayne State University, Detroit, MI; 
2Tulane University, New Orleans, LA
MOC pm 3:10 Ion Mobility Mass Spectrometry of 
Supramolecular Polymers; Chrys Wesdemiotis;
Xiaopeng Li; Wen-Bin Zhang; Stephen Z. D. 
Cheng; The University of Akron, Akron, OH
MOC pm 3:30 Methylation of Pendant Groups to Enable end-
Group Characterization in MAA-based 
Copolymers; Rémi Giordanengo1; Stéphane 
Viel1; Manuel Hidalgo2; Béatrice Allard-Breton2;
André Thévand1; Laurence Charles 1; 1Universités 
Aix-Marseille, Marseille, France; 2Arkema, 
Pierre-Bénite, France
MOC pm 3:50 Electron Induced Dissociation: A New Method 
of Characterising Polymers; Michael Smith;
Jackie Mosely; Durham University, Durham, UK
MOC pm 4:10 Characterization of Hydrogenation Reactions 
and Products of 1,4-bis(phenethyl)benzene 
(DEB) with High-Resolution Mass 
Spectrometry; Steven Thornberg; James 
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Hochrein; Sandia National Laboratories, 
Albuquerque, NM
2:30 – 4:30 PM, MONDAY AFTERNOON 
QUALITATIVE ANALYSIS OF  
PROTEIN THERAPEUTICS BY MS 
Guodong Chen, presiding 
Room 155 
MOD pm 2:30 Application of Mass Spectrometry in the 
Development of Protein Therapeutics; Reb 
Russell; Bristol-Myers Squibb Co., Princeton, 
New Jersey
MOD pm 2:50 Disulfide Linkages of an Albumin Fusion 
Protein; Andrea Meeler; Mark Hesselberg; Angie 
Deng; Michael Byrne; Zhuchun Wu; Human
Genome Sciences, Inc., Rockville, MD
MOD pm 3:10 A Tris (2-Carboxyethyl) Phosphine (TCEP) 
Related Cleavage on Cysteine-Containing 
Proteins; Li Tao; Peiran Liu; Bethanne Warrack; 
Wei Wu; Yunping Huang; Guodong Chen; Reb 
Russell; Bristol-Myers Squibb Co., Pennington, 
NJ
MOD pm 3:30 Mass Spectrometry Methods to Analyze 
Higher Order Structure of Protein 
Therapeutics; Lisa Jones1; Justin Sperry 2; James 
Carroll2; Michael L. Gross1; 1Washington 
University, St. Louis, MO; 2Pfizer, Chesterfield, 
MO
MOD pm 3:50 Aglycosylation Alters Protein Conformation in 
Antibodies Engineered with Specific Effect or 
Functions; Damian Houde 1, 3; Christopher 
Reyes1; Tiffany Chen2; Steven Berkowitz1; Dane 
Wittrup2; John R. Engen3; 1Biogen Idec, 
Cambridge, MA; 2MIT, Cambridge, MA; 
3Northeastern University, Boston, MA
MOD pm 4:10 Characterizing Biotherapeutic Protein 3D 
Structures by Electrospray Ion-Mobility Mass 
Spectrometry: Biological Significance and 
Comparison with X-ray Crystallography and 
NMR Measurements; Weibin Chen; Asish 
Chakraborty; St John Skilton; Scott Berger; Jeff 
Mazzeo; Waters Corporation, Milford, MA
2:30 – 4:30 PM, MONDAY AFTERNOON 
LC-MS CHALLENGES / SOLUTIONS FOR MONITORING 
HUMAN METABOLITES IN SAFETY TESTING (MIST) 
Chandra Prakash, presiding 
Room: Hall 2 
MOE pm 2:30 How to Deal with Human Metabolites in Safety 
Testing (MIST): An Overview; Natalia Penner;
Lewis Klunk; Chandra Prakash; Biogen Idec, 
Cambridge, MA
MOE pm 2:50 Mass Spectrometry Solutions for an Overall 
Metabolite Monitoring Strategy; Ragu 
Ramanathan; Nirmala Raghavan; Donglu Zhang; 
Lifei Wang; Hong Cai; S. Nilgun Comezoglu; 
Jonathan L. Josephs; William Humphreys; 
Bristol-Myers Squibb, Princeton, NJ
MOE pm 3:10 Method Development for Biological Sample 
Processing and Metabolite Profiling by LC-MS 
in Drug Development; Joanna Pols; Swapan K. 
Chowdhury; Kevin Alton; Merck Research 
Laboratories, Kenilworth, NJ
MOE pm 3:30 To the Detection and Quantification of Drug 
Metabolites Using the Simultaneous Collection 
of MRM and MS/MS Data: A Case Study;
Warren Potts1; Ian Wilson3; Rob Plumb2; 1Waters 
Corporation, Milford, MA; 2Imperial College, 
London, UK; 3Astra Zeneca DMPK, Alderly Park 
Maccesfield, Manchester UK
MOE pm 3:50 Semi-Quantitation of Metabolites across 
Species for Direct and Quantitative Evaluation 
of MIST Coverage; Hongying Gao; Shibing 
Deng; R. Scott Obach; Pfizer, Inc, Groton, CT
MOE pm 4:10 Effect of Mobile Phase pH and Aqueous-
Organic Ratio on MS/MS Fragmentation 
Pattern: Implications in LC-MS/MS 
Bioanalysis; Jian Wang; Anne Aubry; Mark S. 
Bolgar; Timothy Olah; Mohammed Jemal; 
Bristol-Myers Squibb, Princeton, NJ
2:30 – 4:30 PM, MONDAY AFTERNOON 
QUANTITATION OF BIOLOGICS: 
APPLICATIONS AND TECHNIQUES 
Jon Williams, presiding 
Room: Hall 3 
MOF pm 2:30 Quantitative Measurement of Biologics Using 
Mass Spectrometry: An Overview; Patrick J. 
Rudewicz; Elan Pharmaceuticals, South San 
Francisco, CA
MOF pm 2:50 Integrated Label-Free Quantitative Analysis of 
the Lung Proteome, Secretome, and 
Phosphoproteome in a Model of Acute Lung 
Injury; Matthew W. Foster; Erik J. Soderblom; J. 
Will Thompson; Harvey E. Marshall; Arthur M. 
Moseley; Duke University School of Medicine, 
Durham, NC
MOF pm 3:10 A Novel Quantitative Approach for Sulfated 
Cholecystokinin CCK-8 in Plasma Using 
Immunoprecipitation LC-MS/MS; Scott 
Young1; Samir Julka1; Glenn Bartley2; Jeffrey 
Gilbert3; Brian Wendelburg3; Shao-Ching Hung1;
Kerr Anderson1; Wallace Yokoyama2; 1Dow
Chemical Company, Midland, MI; 2Western 
Regional Research Center, USDA, Albany, CA; 
3Dow AgroSciences, Indianapolis, IN
MOF pm 3:30 Supporting Therapeutic Antibody Programs 
with Total Target Biomarker Quantitation by 
Sensitive Immunoaffinity LC-MS/MS – 
Validation and Implementation in Clinical 
Trials; Hendrik Neubert; Pfizer Corporation, 
Sandwich, Kent, UK
MOF pm 3:50 Comparison of Different Mass Spectrometry 
Techniques for Quantitative Analysis of 
Peptide Drugs at Low pg/ml Levels in 
Biological Samples; Anders Sonesson; Anna-
Karin Wendel; Lasse Skov Jensen; Magnus 
Knutsson; Alf Carlshaf; Ferring Pharmaceuticals 
A/S, Copenhagen S, Denmark
MOF pm 4:10 Quantitation of Therapeutic Peptides and 
Oligonucleotides Using High-Resolution Mass 
Spectrometry: Benefits and Considerations;
J.C. Yves Leblanc; J. Larry Campbell; AB SCIEX, 
Concord, On, Canada 
2:30 – 4:30 PM, MONDAY AFTERNOON 
PHOSPHOPROTEOMICS APPLICATIONS 
Jesper Olsen, presiding 
Room: Hall 4 
MOG pm 2:30 System-Wide Temporal Characterization of 
the Proteome and Phosphoproteome of 
Differentiating Human Embryonic Stem Cells;
Kristoffer T. G. Rigbolt1; Tatyana A. 
Prokhorova1; Vyacheslav Akimov1; Jeanette 
Henningsen1; Irina Kratchmarova1; Moustapha 
Kassem2; Matthias Mann3; Jesper V. Olsen4;
Blagoy Blagoev1; 1University of Southern 
